Plasma growth differentiation factor 15: a novel tool to detect early changes of hereditary transthyretin amyloidosis

AIMS: Hereditary transthyretin (ATTRv) amyloidosis is the most frequent and representative form of autosomal dominant hereditary systemic amyloidosis. Disease‐modifying treatments of the disease are more effective during the early stages, and we require biomarkers to detect early pathological change...

Descripción completa

Detalles Bibliográficos
Autores principales: Okada, Masamitsu, Misumi, Yohei, Masuda, Teruaki, Takashio, Seiji, Tasaki, Masayoshi, Matsushita, Hiroaki, Ueda, Akihiko, Inoue, Yasuteru, Nomura, Toshiya, Nakajima, Makoto, Yamashita, Taro, Shinriki, Satoru, Matsui, Hirotaka, Tsujita, Kenichi, Ando, Yukio, Ueda, Mitsuharu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006664/
https://www.ncbi.nlm.nih.gov/pubmed/33381924
http://dx.doi.org/10.1002/ehf2.13176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006664/
https://www.ncbi.nlm.nih.gov/pubmed/33381924
http://dx.doi.org/10.1002/ehf2.13176

Ejemplares similares